Every financial statement,
one clean chart.
Search any US-listed company. Data straight from SEC filings.
Kodiak Sciences Inc. (KOD), most recent 12 months reported: net loss $241.99M, free cash flow -$159.9M. Latest balance sheet on file: liquid cash $125.9M. From SEC filings. More on Kodiak Sciences Inc.: Profitability · Cash flow · Debt Others in Biological Products, (No Diagnostic Substances): INTENSITY THERAPEUTICS, INC. · Quince Therapeutics, Inc. · Jasper Therapeutics, Inc. · KALARIS THERAPEUTICS, INC. · Kyverna Therapeutics, Inc. · LIMINATUS PHARMA, INC. · LeonaBio, Inc. · Lexeo Therapeutics, Inc.
Filter every US company by the numbers — net cash, margins, ROIC, growth. Looking for one company? The search box above is free.
Follow a company and we'll email you when it files a quarterly or annual report with the SEC. Free follows 3 companies; Pro follows up to 500, and sorts and filters them.